Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 · Nature Communications · 429 citations
https://doi.org/10.1038/ncomms7656
J
Jack L. Arbiser
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
401
Papers
17.2K
Citations
72
h-index
217
i10-index
Jack L. Arbiser is an academic researcher from Emory University. The author has contributed to research in topics: Magnolia and Illicium research & Vascular Tumors and Angiosarcomas & Angiogenesis and VEGF in Cancer. The author has an h-index of 72, co-authored 341 publications.
ORCID: 0000-0002-6798-6383Papers by this author
worksDesigning a broad-spectrum integrative approach for cancer prevention and treatment
2015 · Seminars in Cancer Biology · 294 citations
https://doi.org/10.1016/j.semcancer.2015.09.007
Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
2017 · Oncotarget · 190 citations
https://doi.org/10.18632/oncotarget.16133
Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition
2017 · Journal of Biological Chemistry · 84 citations
https://doi.org/10.1074/jbc.m117.786442
Disruption of the mitochondrial thioredoxin system as a cell death mechanism of cationic triphenylmethanes
2011 · Free Radical Biology and Medicine · 63 citations
https://doi.org/10.1016/j.freeradbiomed.2010.12.036
HMG-CoA synthase 1 is a synthetic lethal partner of BRAFV600E in human cancers
2017 · Journal of Biological Chemistry · 40 citations
https://doi.org/10.1074/jbc.m117.788778
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat